Adverse Effects | VATS | MIPI | Hybrid | ||||||
---|---|---|---|---|---|---|---|---|---|
k | Prop | 95% CI | k | Prop | 95% CI | k | Prop | 95% CI | |
Anaphylactic shock | 1 | 1.82 | 0.26; 11.81 | - | - | - | - | - | - |
Arteriovenous fistula | - | - | - | - | - | - | - | - | - |
Atrial flutter / tachycardia | 1 | 3.13 | 0.44; 19.11 | - | - | - | 1 | 2 | 0.28; 12.88 |
Atrioesophageal fistula | - | - | - | - | - | - | 1 | 0 | 0.00; 1.00 |
Cardiac tamponade | 1 | 3.13 | 0.44; 19.11 | - | - | - | 2 | 3.31 | 0.01; 95.63 |
Chest infection | - | - | - | 1 | 3.64 | 0.91; 13.41 | - | - | - |
Death | 3 | 5.07 | 1.00; 22.09 | 3 | 0 | 0.00; 1.00 | 1 | 0 | 0.00; 1.00 |
Diaphragm paralysis | - | - | - | - | - | - | - | - | - |
Femoral pseudoaneurysm | 2 | 0 | 0.00; 1.00 | - | - | - | 1 | 5.26 | 0.74; 29.39 |
Groin hematoma/bleed | 2 | 0 | 0.00; 1.00 | 2 | 0 | 0.00; 1.00 | 2 | 1.65 | 0.00; 99.31 |
Heart failure | 1 | 1.67 | 0.23; 10.9 | 2 | 0 | 0.00; 1.00 | - | - | - |
Myocardial infarction | - | - | - | - | - | - | 2 | 0 | 0.00; 1.00 |
Pericardial effusion | 1 | 1.89 | 0.27; 12.21 | 1 | 4.35 | 0.61; 25.22 | - | - | - |
Phrenic nerve injury | - | - | - | 1 | 4.35 | 0.61; 25.22 | 1 | 0.98 | 0.14; 6.63 |
Pneumonia | 1 | 5.66 | 1.84; 16.13 | 1 | 3.28 | 0.82; 12.18 | - | - | - |
pneumothorax | 1 | 9.37 | 3.06; 25.35 | - | - | - | - | - | - |
Postinterventional pericarditis | - | - | - | 1 | 1.64 | 0.23; 10.73 | - | - | - |
PV stenosis | - | - | - | 2 | 0 | 0.00; 1.00 | 2 | 0 | 0.00; 1.00 |
Sepsis, abscesses, or endocarditis | 3 | 5.47 | 1.07; 23.55 | 1 | 1.64 | 0.23; 10.73 | 1 | 5.26 | 0.74; 29.39 |
Stroke | 1 | 1.89 | 0.27; 12.21 | 3 | 0 | 0.00; 1.00 | 1 | 0 | 0.00; 1.00 |
Transient ST elevation | - | - | - | - | - | - | - | - | - |
TIA | 1 | 0 | 0.00; 1.00 | 3 | 0 | 0.00; 1.00 | 1 | 0.98 | 0.14; 6.63 |